MISTNasdaqPharmaceutical Preparations

Milestone Pharmaceuticals Inc. (MIST) earnings date, market-implied expected move, and options open interest by expiry

0.77

+0.01 · +1.91%

post 0.79 +1.76%

Closed16:43 ET

Open0.77Volume688,975Mkt cap$94.5MEPS-0.65

Day0.75 – 0.79100%52-wk0.63 – 3.066%

MIST

Milestone Pharmaceuticals Inc.

OpenVolumeMkt capP/EEPSDiv yield

Day – 52-wk –

Expected move

No implied move.

Expected move

Inputs

Next report

Nov 11

before open · in 7 days

est.Q3 FY26

Calendar

Next report

Last report

−11.42%

vs ±57.2% implied · ×0.20

shaded = implied · ▲▼ = realized

Aug 12 '26 · confirmed

Implied vs realized

Largest filed tie

—

13F top-10 QoQ

+41.25%

shares held · 10 largest managers

13F · Jun 30 '26128d lag

78 managers

Top fund weight

—

Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied

Milestone Pharmaceuticals (MIST) is expected to report on Nov 11 before open (estimated date).

Implied vs realized

1 report

—≥ implied

Q2 FY26Aug 12 '26confirmed±57.2%▼−11.42%×0.20

quarterimplied−60%0+60%realized×

Q2 FY26±57.2%▼−11.42%×0.20

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Implied vs realized

Positioning

OI · 3 expiries · Oct 28 close

0.01OI · 3 expiries · Oct 28 closeP/C open interest · Nov 20 · first expiry after the report

PUTS · chgexpiry · days · P/CCALLS · chgP/C

14+40%Nov 2016d1,852+5%

6760%Dec 1844d0.088,442+1%0.08

5250%Mar 19135d0.0510,386+2%0.05

ExpiryPutsCallsP/C

Nov 2016d14+40%1,852+5%0.01

Dec 1844d6760%8,442+1%0.08

Mar 19135d5250%10,386+2%0.05

Hatched = puts · solid = calls · bars scaled per expiry · chg = OI vs prior sessionSource: options EOD

Positioning

Linked exposure

No linked exposure.

Linked exposure

Revenue flow

as filedQ2 FY26

−5118.78%as filednet margin · revenue +134.87% QoQ

Revenue$559,000+134.87%

Gross profit$527,00094.28%+135.27%

Operating income−$26M−4584.97%−8.31%

Pre-tax income−$29M−9.78%

Net income−$29M−5118.78%−9.78%

Cost of revenue$32,000+128.57%

Operating expenses$26M+9.50%

Other expense−$3M−24.18%

Source: SEC filings · standardized · QE Jun 30 '26 · bars = % of revenue

Revenue flow

Intraday

15m bars

Hatch = extended hours · ▯ up · ▮ downSource: market data · 16:30 ET

Intraday

Event sensitivity

PCE ×1.81· ±6.1% vs ±3.4% · 19 releases

eventrelease day|move|up · n×base

PCEpersonal income & outlays±6.1%10 of 19×1.81

CPROFcorporate profits±4.5%9 of 12×1.34

PPIproducer prices±3.5%4 of 10×1.05

GDPgross domestic product±3.5%12 of 19×1.04

FOMCrate decision±3.5%9 of 24×1.02

CPIconsumer prices±3.1%3 of 10×0.91

NFPjobs report±2.6%2 of 10×0.77

Bar = avg |move| to ±7% · tick = ±3.4% avg day · ×base = |move| ÷ ±3.4% · min 6 releases

Earnings history

EPS -0.21 · consensus —

Quarter	Reported	EPS	Consensus
Q2 FY26	Aug 12 '26 · confirmed	-0.21	—
Q1 FY26	—	-0.20	—
Q3 FY25	—	-0.12	—

Source: filed financials

Methodology

ties · implied moves · holdersMethod